Atlas Venture raised $450m for its fourteenth biotech round, while Nuvig, ... with Janus Henderson Investors, Logos Capital, Third Rock Ventures, ... Novo Nordisk teams up with NVIDIA on AI models .

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge ...

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

View the latest Novo Nordisk A/S (NOVO.B) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Data on Novo Nordisk experimental weight-loss drug show mostly mild side effects CagriSema combines Wegovy with a molecule that mimics a hunger-suppressing hormone. June 21, 2025 China's Sciwind's ...

Novo Nordisk has reached the end of its two-year suspension from the Association of the British Pharmaceutical Industry (ABPI) for breaches of its code of practice, after showing "significant and ...

A high-level overview of Novo Nordisk A/S (NVO) stock. View (NVO) real-time stock price, chart, news, analysis, analyst reviews and more.

Read about Novo Nordisk AS ADR (NVO:XNYS) stock and today's latest news and financial updates. NVO - Novo Nordisk AS ADR News | Morningstar Morningstar brands and products ...

Review quarterly and annual revenue, net income, and cash flow for Novo Nordisk AS ADR (NVO:XNYS) stock through the last fiscal year.

The New England Journal of Medicine (NEJM) published results from Novo Nordisk's phase 3 REDEFINE 1 trial evaluating the efficacy and safety of investigational CagriSema plus lifestyle interventions ...